Keywords
number of embryos - morphological evaluation - embryo quality - clinical pregnancy
- ICSI
Palavras-chave
número de embriões - avaliação morfológica - qualidade embrionária - gravidez clínica
- ICSI
Introduction
Infertility, defined as the absence of conception after a year of unprotected sexual
activity, has a high prevalence in the general population, affecting ∼ 5 to 15% of
couples in reproductive age.[1]
[2] The assisted reproduction techniques (ART) are procedures that include in vitro
manipulation of gametes (eggs and sperm) and embryos for the purpose of establishing
a pregnancy.[3]
[4] In developed countries, ∼ 5% of all births are resultant of ART, which is an important
treatment indicated to infertile couples.[5]
[6] For ART, women are submitted to controlled ovarian stimulation (COS) with artificial
hormones.[7]
[8]
[9] This strategy aims to obtain a greater number of oocytes and embryos, enabling an
increase of cumulative pregnancy rate per cycle.[10]
[11] However, we question whether the total number of formed embryos has an influence
in the pregnancy rate in the first fresh transfer cycle.
The conventional morphological evaluation is used as an indirect method for checking
the quality and the potential of embryonic development; however, the analyzed parameters
still diverge.[12]
[13] To homogenize the conventional morphological evaluation, experts in the issue created
the Istanbul Consensus.[13] Based on this consensus, a top quality embryo (TQE) on the second day of development
(D2) has 4 cells Grade 1 (symmetrical blastomeres, with less than 10% of fragmentation
and without multinucleation), and on the third day of development (D3), has 8 cells
Grade 1.[13] Some studies suggest that the implantation rate is positively influenced by the
morphology of transferred embryos: the TQEs, for example, present greater potential
for implantation and to generate live births compared with embryos with worse morphology.[12]
[13]
[14]
Thus, we question if, apart from the assessment of embryo morphology, the number of
produced embryos per cycle is also related to pregnancy rates in the first fresh transfer
cycle. Elucidating the impact of the number of formed embryos together with embryonic
morphology can help determine the gestational outcomes, adjusting the expectations
of patients and physicians. Therefore, the aim of this study was to compare the clinical
pregnancy rate in the first fresh transfer cycle of women who formed and transferred
at least 1 embryo, divided into 6 groups according to the number of formed embryos
(1, 2–3 and ≥ 4) and transfer or not of at least 1 TQE in D2 or D3.
Methods
This retrospective cohort study evaluated all women who underwent COS for intracytoplasmic
sperm injection (ICSI) at the fertility clinic of the Hospital das Clínicas da Faculdade
de Medicina de Ribeirão Preto, Universidade de São Paulo, Brazil, between January
2011 and December 2012. All data were obtained from medical records by one author
(MACN). The study protocol was approved by the Institutional Review Board (# 9682/2012),
which waived the requirement for additional informed consent due to the retrospective
nature of the study.
Women younger than 40 years submitted to COS for ICSI who had at least 1 embryo formed
and transferred in cleavage stage in the first fresh cycle were considered eligible.
If the patient had been subjected to more than one COS cycle during this period, only
data from the first cycle were included in the analysis. All women were followed-up
until a negative pregnancy test or until the first ultrasound performed two to three
weeks after the positive pregnancy test.
Patients were stratified into 3 groups according to the number of formed embryos in
cleavage stage (1 embryo; 2–3 embryos and ≥ 4 embryos). Each group was subdivided
into two subgroups (with or without TQE), transferred in the first fresh cycle (1
with TQE; 1 without TQE; 2–3 with TQE, 2–3 without TQE; ≥ 4 with TQE; ≥ 4 without
TQE). Patients who had formed two or more embryos transferred only two embryos in
the fresh cycle.
All included patients had menstruation programmed with oral combined contraceptives,
starting during the previous menstrual cycle. The COS was started five days after
the discontinuation of oral contraceptives. The transvaginal ultrasound was performed
on the first day of the COS to assess the endometrial pattern and rule out the presence
of ovarian cysts. These may interfere in the response to exogenous gonadotropins or
in the monitoring of follicle growth by ultrasound.[15]
Three COS protocols could be used: in the standard long protocol, the use of gonadotropin-releasing
hormone (GnRH) agonists (leuprolide acetate 0.5 mg/day) was initiated during the luteal
phase of the previous cycle, followed by gonadotropin (150–300 UI/day) during the
first days of COS. Subsequently, the daily dose of gonadotropin was adjusted according
to follicular growth.
In the flexible antagonist protocol, gonadotropin (150–300 IU/day) was administrated
during the first 6 days of COS, with a daily dose adjusted according to follicular
growth. Gonadotropin-releasing hormone antagonists (cetrorelix or ganirelix 0.25 mg/day)
were administered on the day that the average diameter of the largest follicle was ≥ 14
mm.
The minimal stimulation protocol (clomiphene citrate [CC] plus gonadotropins and GnRH
antagonist) was offered to some women with low antral follicle count (AFC; AFC ≤ 6).[15] The CC (100 mg/day) was administered during the first 5 days of COS, and gonadotropins
(150 UI/day) were administered on days 2 and 4, and daily from day 6 on. The GnRH
antagonist (cetrorelix or ganirelix 0.25 mg/day) was administered on the day that
the average diameter of the largest follicle was ≥ 14 mm.
The recombinant human chorionic gonadotrophin (hCG [250 mcg, Ovidrel®, Serono, Brazil]),
or urinary hCG (10,000 IU Choriomon®, Meizler, Brazil) was administered when at least
1 follicle with a mean diameter of 18 mm was present. Oocytes were obtained 34–36
hours after administration of the recombinant hCG, and the luteal phase was maintained
by administration of micronized progesterone (600 mg/day).
The mature oocytes were subjected to ICSI and cultured individually. Fertilization
was defined as the presence of two pronuclei and two polar bodies. Embryo quality
was evaluated ∼ 43 and 45 hours after ICSI (second day of embryonic development),
based on the number and symmetry of blastomeres' percentage of fragmentation and presence
or absence of multinucleation. If the embryo transfer was not performed in D2, embryo
quality was analyzed ∼ 67 to 69 hours after ICSI (D3).[13]
The D2 embryos with 4 symmetrical blastomeres, normal sized, with < 10% fragmentation,
and without multinucleation were considered top quality.[13] Embryos on the third day of development and with 8 symmetrical blastomeres, normal
sized, with < 10% of fragmentation, and without multinucleation were also considered
top quality.[13]
The clinical pregnancy rate per cycle was defined as the number of patients that presented
an ultrasound (4 to 5 weeks after transfer) with embryo heartbeat divided by the number
of cycles × 100.
The primary endpoint of this study was the rate of clinical pregnancy. The following
parameters were assessed: age, weight, height, body mass index (BMI), duration and
etiology of infertility, antral follicle count (AFC), protocol used for COS, number
of retrieved oocytes, number of captured metaphase II (MII) oocytes, number of formed
embryos, of transferred embryos and of TQEs. All data were obtained from medical records.
Statistical Analyses
The study size was defined as the total number of eligible patients (women younger
than 40 years submitted to COS for ICSI who had at least 1 embryo formed and transferred
in cleavage stage in the first fresh cycle) during the study period.
First, women were stratified into 3 groups according to the number of cleavage stage
formed embryos (1 embryo; 2–3 embryos and ≥ 4 embryos). Then, each group was divided
into two subgroups according to the presence or absence of at least one transferred
TQE; clinical pregnancy rates and other variables were compared in each group as described
below.
The normal distribution of continuous variables was analyzed using the Kolmogorov-Smirnov
test. Continuous variables with normal distribution were presented as mean ± standard
deviation (SD) and compared between the groups with and without TQE by unpaired t-test. Continuous variables without normal distribution were presented as median (interquartile
range), and comparisons were made by Mann-Whitney test. Binary data were presented
as a ratio (%) and compared using Fisher's exact test. The level of significance was
defined as p < 0.05. All statistical analyzes were performed using the SPSS software (version
18.0, SPSS Inc., Chicago, IL, US). For the additional analysis, we determined the
power of the study to detect a difference of 10% in clinical pregnancy rates among
women with one embryo; 2–3 embryos and ≥ 4 embryos.
Results
Within the study period, 792 women were subjected to ICSI. Among these women, 130
patients had no available embryos after oocyte retrieval, 19 did not transfer fresh
embryos, 1 patient had the embryo culture extended to blastocyst, and 6 had no full
records of morphological evaluation in the medical records. The 636 remaining patients
(who had at least one embryo to be transferred in the same cycle) were followed until
a negative pregnancy test or until the transvaginal ultrasound (TVU), four to five
weeks after transfer.
Of the 636 patients included in the study, 17.8% had 1 available embryo (32.7% with
TQE versus 67.3% without TQE), 42.1% of women had 2–3 available embryos (55.6% with
TQE versus 44.4% without TQE), and 1% of patients had ≥ 4 available embryos (73.7%
with TQE versus 26.3% without TQE).
Within each group (1, 2–3 and ≥ 4), there were no statistically significant differences
in the patients' age, weight, height, BMI, cause of infertility, duration of infertility,
AFC, COS protocols ([Table 1]), number of retrieved oocytes and MII oocytes compared with women who had transferred
or not at least 1 TQE. However, the number of embryos was significantly higher in
patients in groups 2–3 and ≥ 4 embryos with TQE compared with the groups without TQE
([Table 2]).
Table 1
Characteristics of the included participants depending on the number of available
embryos and on the presence of embryo(s) considered as having top morphologic criteria
|
Groups
|
1 embryo
|
2–3 embryos
|
≥ 4 embryos
|
|
Subgroups
|
Without TQE
|
With TQE
|
p
|
Without TQE
|
With TQE
|
p
|
Without TQE
|
With TQE
|
p
|
|
N
|
76
|
37
|
|
119
|
149
|
|
67
|
188
|
|
|
Parameter
|
|
Age
|
35.7 ± 4.4
|
34.7 ± 4.7
|
0.27
|
34.6 ± 4.1
|
34.0 ± 4.5
|
0.26
|
33.4 ± 3.7
|
33.4 ± 4.1
|
0.91
|
|
Weight
|
69.1 ± 11.8
|
70.7 ± 15.7
|
0.60
|
64.8 ± 12.1
|
67.1 ± 12.8
|
0.15
|
65.2 ± 12.0
|
65.2 ± 10.7
|
0.98
|
|
Height
|
1.65 ± 0.06
|
1.65 ± 0.06
|
0.70
|
1.63 ± 0.07
|
1.64 ± 0.06
|
0.42
|
1.64 ± 0.06
|
1.63 ± 0.06
|
0.16
|
|
BMI
|
25.5 ± 4.3
|
25.4 ± 5.2
|
0.73
|
24.4 ± 4.1
|
25.1 ± 4.4
|
0.23
|
24.3 ± 4.1
|
24.6 ± 3.7
|
0.53
|
|
AFC
|
6 [4–11]
|
7 [4–14]
|
0.49
|
11 [7–15]
|
9 [6–16]
|
0.54
|
16 [11–25]
|
16 [11–21]
|
0.31
|
|
Duration of infertility
|
70 [43–105]
|
58 [41–87]
|
0.33
|
58 [36–88]
|
54 [28–77]
|
0.23
|
62 [37–91]
|
51 [32–77]
|
0.14
|
|
Cause of infertility
|
|
|
0.15
|
|
|
0.68
|
|
|
0.68
|
|
Ovulatory
|
4 (5%)
|
1 (3%)
|
|
8 (7%)
|
11 (7%)
|
|
1 (1%)
|
7 (4%)
|
|
|
Endometriosis
|
13 (17%)
|
5 (14%)
|
|
13 (11%)
|
24 (16%)
|
|
9 (13%)
|
21 (11%)
|
|
|
Male
|
21 (28%)
|
4 (11%)
|
|
34 (29%)
|
39 (26%)
|
|
15 (22%)
|
58 (31%)
|
|
|
Tubal
|
5 (7%)
|
2 (5%)
|
|
15 (13%)
|
14 (9%)
|
|
5 (7%)
|
14 (7%)
|
|
|
Combined
|
25 (33%)
|
22 (59%)
|
|
39 (33%)
|
53 (36%)
|
|
27 (40%)
|
69 (37%)
|
|
|
Unexplained
|
8 (11%)
|
3 (8%)
|
|
10 (8%)
|
8 (5%)
|
|
10 (15%)
|
20 (11%)
|
|
|
Ovarian stimulation protocol
|
|
|
0.96
|
|
|
0.79
|
|
|
0.10
|
|
FSH + Ant
|
45 (59%)
|
22 (59%)
|
|
79 (66%)
|
101 (68%)
|
|
51 (76%)
|
149 (79%)
|
|
|
FSH + Ago
|
12 (16%)
|
5 (14%)
|
|
30 (25%)
|
33 (22%)
|
|
13 (19%)
|
38 (20%)
|
|
|
CC + FSH + Ant
|
19 (25%)
|
10 (27%)
|
|
10 (8%)
|
15 (10%)
|
|
3 (4%)
|
1 (1%)
|
|
Abbreviations: AFC, antral follicle count; BMI, body mass index; CC, clomiphene citrate;
FSH+Ago, agonist protocol with follicle-stimulating hormone; FSH+Ant, antagonist protocol with follicle-stimulating hormone; N, number of women analyzed; TQE, top quality embryo.
Note: Data presented as mean ± SD, median [interquartile range], or number (proportion).
Table 2
Main outcomes depending on the number of available embryos and on the presence of
embryo(s) considered as having top morphologic criteria
|
Groups
|
1 embryo
|
2–3 embryos
|
≥ 4 embryos
|
|
Subgroups
|
Without TQE
|
With TQE
|
p
|
Without TQE
|
With TQE
|
p
|
Without TQE
|
With TQE
|
p
|
|
N
|
76
|
37
|
|
119
|
149
|
|
67
|
188
|
|
|
Parameter
|
|
Retrieved oocytes
|
2 [1–3]
|
2 [1–4]
|
0.86
|
5 [4–7]
|
5 [4–7]
|
0.68
|
10 [7–12]
|
10 [8–14]
|
0.25
|
|
MII retrieved
|
2 [1–3]
|
1 [1–3]
|
0.45
|
4 [3–6]
|
4 [3–5]
|
0.42
|
7 [6–10]
|
9 [6–11]
|
0.07
|
|
Formed embryos
|
1 [1–1]
|
1 [1–1]
|
1.00
|
2 [2–2]
|
2 [2–3]
|
< 0.01*
|
4 [4–6]
|
5 [4–7]
|
< 0.01*
|
|
Transferred embryos
|
1 [1–1]
|
1 [1–1]
|
1.00
|
2 [2–2]
|
2 [2–2]
|
0.94
|
2 [2–2]
|
2 [2–2]
|
0.64
|
|
Clinical pregnancy
|
7 (9.2%)
|
6 (16.2%)
|
0.35
|
36 (30.2%)
|
50 (33.5%)
|
0.60
|
19 (28.3%)
|
85 (45.2%)
|
0.02*
|
Abbreviations: MII, metaphase II; N, number of women analyzed; p, p-value; TQE, top quality embryo. * p statistically significant.
Note: Data presented as median [interquartile range], or number (proportion).
Among women who had and transferred only 1 embryo, there was no difference in the
pregnancy rate compared with women with TQE (16.2%) and without TQE (9.2%). Among
those who had 2–3 available embryos, 33.5% of women with TQE and 30.2% of women without
TQE became pregnant, also showing no significant difference between groups. Of the
patients who had 4 or more available embryos, 45.2% of women with TQE and 28.3% of
women without TQE became pregnant. The clinical pregnancy rate was significantly higher
in the subgroup with ≥ 4 available embryos with at least 1 transferred TQE (≥ 4 with
TQE) compared to the subgroup without TQE (≥ 4 without TQE) ([Table 2]).
The present study presented a test power of ∼ 70% to detect a difference of 20% in
clinical pregnancy rates between patients with and without transferred TQE and only
1 available embryo; 40% for the subgroups that had 2–3 available embryos; and 30%
for the subgroups that had ≥ 4 available embryos.
Discussion
Our study evidenced that, during ART, the embryonic morphological evaluation, in the
second or third day of development, is an important factor involved in the prognosis
of clinical pregnancy, especially in women who had four or more embryos. In the group
with ≥ 4 available embryos, there was an increase of ∼ 17% in clinical pregnancy rates
in the subgroup of patients that transferred at least 1 TQE in the first fresh transfer
cycle (45%) compared with those women who had no TQE (28%) transferred. Among the
many plausible conditions to influence pregnancy rates after ART, the number of retrieved
oocytes, the number of available embryos and the number of transferred TQEs seem to
be the most important factors of reproductive prognosis.[16]
[17]
[18]
[19]
[20] However, there are few studies evaluating the relationship between pregnancy rate
and live birth rate and the number and morphological quality of the embryos concomitantly.
In women over 40 years, Opsahl et al[21] found that patients who had less than 4 embryos presented lower chances of pregnancy
than those who formed ≥ 4; however; this study did not take into account the morphology
of the embryos.[21] Corroborating our findings, Van Loendersloot et al[22] suggested that the number of available embryos and their morphological quality in
the third day of culture should be important factors in the development of a model
to predict the probability of pregnancy after in vitro fertilization (IVF).[22]
In the group with 1 embryo, the difference in the clinical pregnancy rates among the
subgroups with TQE (16.2%) and without TQE (9.2%) was 7%. And in the group with 2–3
available embryos, the difference in the clinical pregnancy rates among subgroups
with TQE (33.5%) and without TQE (30.2%) was 3.3%. Despite the fact that these differences
were not statistically significant, this study did not have the adequate test power
to confirm the findings, and studies with larger sample sizes are necessary to evaluate
whether patients who present less than 4 embryos have their pregnancy rates influenced
or not by the morphology of transferred embryos.
Among several analyzed secondary outcomes, in groups with the formation of 2–3 embryos
and ≥ 4 embryos, the number of embryos differed between groups with and without TQEs.
In the group with ≥ 4 embryos, 73.7% of women had TQEs, and just 26.3% did not. These
findings suggest that women who generate a greater number of embryos have a greater
potential to form TQEs.[23] The other evaluated secondary endpoints showed no statistically significant difference
between the subgroups, further reinforcing the findings of the study, excluding the
interference of these parameters on the primary endpoint (clinical pregnancy rate).
Previous researches showed that the quality and size of the embryo cohort allow the
selection of TQEs for transfer in the fresh cycle and, subsequently, in frozen cycles,
thus influencing the cumulative pregnancy rate.[21]
[24] However, both factors, number and quality of embryos together, can be a valuable
tool in predicting the probability of pregnancy after ICSI, adjusting the expectations
of patients and physicians.
Since this is a retrospective study, the information was obtained exclusively from
medical records. Another important point is the relatively small sample size in each
subgroup, so that larger studies are important to confirm our findings and investigate
the influence of embryo morphology on the embryos' cleavage stage in women that had
fewer than 4 embryos per cycle of IVF/ICSI. Since in our analysis we included only
data from the first cycle of each patient, it is not possible to extrapolate whether
the cumulative clinical pregnancy rate, per cycle or time, is different in women with
or without TQEs.
This study allows to more accurately establish the chances of clinical pregnancy per
cycle for patients under 40 years who have at least 1 embryo in the first fresh transfer
cycle. This information is useful when counseling couples in order to determine the
gestational outcomes, adjusting the expectations of doctors and patients.
In conclusion, among women undergoing COS for ICSI, women that had four or more embryos
and transferred at least one TQE in the first fresh transfer cycle have higher rates
of clinical pregnancy compared with those of women without TQEs. Thus, we found that
the number of embryos per cycle and the quality of embryos transferred are important
prognostic factors in ART.
